Alert: New Earnings Report (3/7/24)-EyePoint Pharmaceuticals Inc (NASDAQ: EYPT).
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) has reported E.P.S. of $-0.33 for its fourth fiscal quarter (ending December 31) versus $-1.16 for the same period a year ago. For the latest four quarters through December 31, […]